15 Results for "

SW1990

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "SW1990" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-134929
CAS No.: 2454676-05-0
Purity:  99.91%
Synonyms: BNBZ; Hexokinase 2 inhibitor 1
Target:  

Hexokinase Apoptosis

Research Areas:  

Cancer

Benitrobenrazide (BNBZ) is the orally active inhibitor for hexokinase 2 with an IC50 of 0.53 µM. Benitrobenrazide causes DNA damage, and exhibits antitumor effect .
loading...
    loading...
Cat. No.: HY-174304
Research Areas:  

Cancer

Bis (vinylsulfonyl) piperazine-triazole-PEG3-O-diisopropylsilyl-triptolide is a drug-linker conjugates for ADC. Bis (vinylsulfonyl) piperazine-triazole-PEG3-O-diisopropylsilyl-triptolide consists of Triptolide (HY-32735) and a stable cleavable linker (Bis (vinylsulfonyl) piperazine-triazole-PEG3-O-diisopropylsilyl-Cl) (HY-174810). Bis (vinylsulfonyl) piperazine-triazole-PEG3-O-diisopropylsilyl-triptolide can be used for the synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
Cat. No.: HY-144661
CAS No.: 2765254-39-3
Purity:  99.39%
Target:  

Ras Apoptosis

Research Areas:  

Cancer

KRAS G12D inhibitor 14 is a potent KRAS G12D inhibitor with a KD of 33 nM for binding to KRAS G12D protein. KRAS G12D inhibitor 14 decreases the active form of KRAS G12D (KRAS G12D-GTP) but not KRAS G13D .
loading...
    loading...
Cat. No.: HY-158008
CAS No.: 2946593-60-6
Target:  

Ras

Research Areas:  

Cancer

(R)-G12Di-7 is a covalent ligand for KRAS-G12D, which selectively labels K-Ras-G12D·GDP and K-Ras-G12D·GppNHp. (R)-G12Di-7 exhibits inhibitory activity against G12D mutated cancer cells .
loading...
    loading...
Cat. No.: HY-111934
CAS No.: 508-77-0
Purity:  97.28%
Cymarin, a cardiac glycoside, potently inhibits the Palytoxin (PTX)-induced K + release (IC50=0.42 μM). Cymarin reveals an antitumor activity against breast cancer and pancreatic cancer. Cymarin exhibits antifeedant and growth inhibitory effects as crop protectant .
loading...
    loading...
Cat. No.: HY-135770
CAS No.: 1360606-85-4
9-Dehydroxyeurotinone is an anthraquinone derivative that can be found in Eurotium rubrum. 9-Dehydroxyeurotinone shows cytotoxicity with an IC50 value of 25 µg/mL for SW1990 cells .
loading...
    loading...
Cat. No.: HY-N12147
CAS No.: 1841524-78-4
Cannogenol 3-O-β-gentiobiosyl-(1→4)-α-L-thevetoside (Compound 12) is a cardiac glycoside that can be isolated from seeds of Thevetia peruvian. Cannogenol 3-O-β-gentiobiosyl-(1→4)-α-L-thevetoside shows cytotoxicity against SW1990 and MGC-803 cells (IC50: 9.52 and 7.70 μM) .
loading...
    loading...
Cat. No.: HY-155303
CAS No.: 2978517-43-8
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

DCLK1-IN-2 (compound I-5) is a potent DCLK1 inhibitor with an IC50 of 171.3  nM. DCLK1-IN-2 shows remarkable antiproliferative effects on SW1990 cell lines (IC50 of 0.6 μM) and in vivo antitumor potency .
loading...
    loading...
Cat. No.: HY-N10588
CAS No.: 443128-65-2
Synonyms: 10-epi-Nardoguaianone J
Nardoguaianone K, a guaiane-type compound, can be isolated from Nardostachys chinensis roots. Nardoguaianone K cam be used in the research of pancreatic cancer .
loading...
    loading...
Cat. No.: HY-144338
CAS No.: 2758117-74-5
PARP1/BRD4-IN-1 is a potent and high selective PARP1/BRD4 inhibitor (IC50s of 49 and 202 nM in PARP1 and BRD4, respectively). PARP1/BRD4-IN-1 represses the expression and activity of PARP1 and BRD4 to synergistically inhibit the malignant growth of pancreatic cancer cells .
loading...
    loading...
Cat. No.: HY-146094
CAS No.: 1627600-90-1
Target:  

Topoisomerase

Research Areas:  

Cancer

Antitumor agent-63 (Compound 40), a 20 (S)-O-linked camptothecin (CPT) glycoconjugate, is an antitumor agent without toxicity towards normal cells. Antitumor agent-63 shows high stability and very weak direct topoisomerase I (Topo I) inhibition .
loading...
    loading...
Cat. No.: HY-P990199
Anti-Mouse Ly6G/Ly6C Antibody (NIMP-R14) is an anti-mouse Ly6G/Ly6C IgG2b monoclonal antibody. Anti-Mouse Ly6G/Ly6C Antibody (NIMP-R14) can deplete granulocytes and monocytes. Anti-Mouse Ly6G/Ly6C Antibody (NIMP-R14) can be used for researches on infection conditions and cancer such as pancreatic cancer and Orientia tsutsugamushi infection .
loading...
    loading...
Cat. No.: HY-172210
CAS No.: 3017180-18-3
Research Areas:  

Cancer

DDO-8958 is an orally active and selective BET BD1 inhibitor with a KD of 5.6 nM for BRD4 BD1. DDO-8958 exhibits low nanomolar inhibitory activity against all BET BD1 bromodomains except for BRDT BD1. DDO-8958 can inhibit the proliferation and migration, induce apoptosis and cell cycle arrest of tumor cells. DDO-8958 has anti-tumor activity .
loading...
    loading...
Cat. No.: HY-182749
Target:  

Ras Akt Raf ERK

Research Areas:  

Cancer

KRAS-IN-58 is a KRAS inhibitor with a IC50 of 0.223 μM against KRAS G12D. KRAS-IN-58 binds to KRAS G12C and KRAS G12D proteins, and reduces the levels of phosphorylated Raf1, AKT and ERK in pancreatic cancer cells. KRAS-IN-58 can be used for the research of pancreatic cancer .
loading...
    loading...
Cat. No.: HY-180200
CAS No.: 3032602-44-8
Target:  

Ras ERK

Research Areas:  

Cancer

RNK08954 is an orally active KRASG12D inhibitor with a Kd of 0.0395 nM. RNK08954 selectively binds the inactive GDP-bound KRASG12D form, suppresses downstream KRAS-mediated signaling pathways p-ERK1/2 experssion. RNK08954 inhibits KRASG12D-mutant cell proliferation, induces G0-G1 cell cycle arrest, and inhibits tumor growth in mouse xenograft models. RNK08954 can be used for the research of non-small cell lung cancer, pancreatic ductal adenocarcinoma .
loading...
    loading...
  • 1